+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Molecular Point of Care Diagnostics Market 2019-2028

  • PDF Icon

    Report

  • 110 Pages
  • May 2020
  • Region: North America
  • Triton Market Research
  • ID: 5037206

MARKET OUTLOOK

A report on the North American molecular point of care diagnostics market, indicates that it is expected to flourish with a CAGR of 13.66% over the estimated period 2019-2028.
The United States and Canada together constitute the North American molecular point of care diagnostics market.

The molecular diagnostics point of care market in North America is foreseen to be primarily driven by the advanced technological innovations that are enhancing the overall scope of molecular point of care diagnostics in the region. The research and development projects, emphasized on genetics & pharmacogenomics, have further helped in gaining knowledge of infectious diseases, different cancers and inherited diseases.

The considerable investments made for the development of both targeted therapeutics and molecular diagnostics have aided the US to dominate the market in the past few years. Besides, there is a higher acceptance rate for patients in North America as compared to other regions across the world. All these factors are likely to increase the growth of the molecular point of care diagnostics market.

Many well-established diagnostics manufacturers are trying to expand their product portfolio within the point of care-based molecular diagnostics. These firms are also trying to collaborate with pharmaceutical giants and service providers in order to market molecular diagnostics solutions along with its complementary precision medicine solutions. Additionally, the government of the US is undertaking several initiatives for the promotion of the market and thereby aiding the molecular point of care diagnostics market growth in the coming years.

COMPETITIVE OUTLOOK

Some noteworthy companies in the molecular point of care diagnostics market are Biomerieux SA, QuantuMDx Group Ltd, Biocartis, Danaher, Qiagen, F Hoffmann-La Roche Ltd and Abbott.

Table of Contents

1. North America Molecular Point of Care Diagnostics Market - Summary
2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Fda Issued Emergency Use Authorisation Due to Covid 19 Pandemic
2.2.2. Increased Geriatric Population Requires More Diagnostic Services
2.2.3. North America Region Leads the Market
2.2.4. Hybridization of Available Technologies is a Promising Trend
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Regulatory Framework
2.6.1. United States
2.7. Market Drivers
2.7.1. Demand for Diagnosing Presence of Sars Cov-2
2.7.2. Increasing Demand for Non-Invasive Diagnosis
2.7.3. Rise in the Number of Diseases
2.8. Market Restraints
2.8.1. High Capital Requirement
2.9. Market Opportunities
2.9.1. Spending on Research & Development
2.9.2. Innovations in the Market
2.10. Market Challenges
2.10.1. Lack of High Complexity Testing Centers
3. North America Molecular Point of Care Diagnostics Market Outlook – by Product
3.1. Assays
3.2. Instruments
3.3. Software
4. North America Molecular Point of Care Diagnostics Market Outlook - by Application
4.1. Infectious Disease
4.1.1. Respiratory
4.1.2. Hospital-Acquired Infections
4.1.3. Sexually-Transmited Infections
4.1.4. Gastrointestinal Infections
4.2. Oncology
4.3. Prenatal
4.4. Others
5. North America Molecular Point of Care Diagnostics Market Outlook - by Technology
5.1. Polymerase Chain Reaction
5.1.1. Real-Time Pcr (Q-Pcr)
5.1.2. Digital Pcr (D-Pcr)
5.2. Isothermal Nucleic Acid Amplification Technology
5.3. Other
6. North America Molecular Point of Care Diagnostics Market Outlook - by End-User
6.1. Hospital
6.2. Clinics
6.3. Diagnostic Centers
6.4. Others
7. North America Molecular Point of Care Diagnostics Market – Regional Outlook
7.1. United States
7.2. Canada
8. Competitive Landscape
8.1. ABBott
8.2. Abacus Diagnostica
8.3. Biomerieux Sa
8.4. Biocartis
8.5. Danaher
8.6. Diasorin Spa
8.7. Bio-Rad Laboratories Inc
8.8. F Hoffmann-La Roche Ltd
8.9. Luminex Corporation
8.10. Hologic Inc
8.11. Mesa Biotech
8.12. Spartan Biosciences Inc
8.13. Quantumdx Group Ltd
8.14. Quidel Corporation
8.15. Qiagen
9. Methodology & Scope
9.1. Research Scope
9.2. Sources of Data
9.3. Research Methodology
List of Tables
Table 1: North America Molecular Point of Care Diagnostics Market, by Country, 2019-2028 (In $ Million)
Table 2: Emergency Use Authorisation for Diagnostics by Fda
Table 3: Market Attractiveness Index
Table 4: Vendor Scorecard
Table 5: North America Molecular Point of Care Diagnostics Market, by Product, 2019-2028 (In $ Million)
Table 6: North America Molecular Point of Care Diagnostics Market, by Application, 2019-2028 (In $ Million)
Table 7: North America Molecular Point of Care Diagnostics Market, by Infectious Disease, 2019-2028 (In $ Million)
Table 8: North America Molecular Point of Care Diagnostics Market, by Technology, 2019-2028 (In $ Million)
Table 9: North America Molecular Point of Care Diagnostics Market, by Polymerase Chain Reaction, 2019-2028 (In $ Million)
Table 10: North America Molecular Point of Care Diagnostics Market, by End-User, 2019-2028 (In $ Million)
Table 11: North America Molecular Point of Care Diagnostics Market, by Country, 2019-2028 (In $ Million)
List of Figures
Figure 1: Porter's Five Force Analysis
Figure 2: Cost Comparison Between Laboratory, Immunoassay and Molecular Poc Diagnostic Tests
Figure 3: North America Molecular Point of Care Diagnostics Market, by Assays, 2019-2028 (In $ Million)
Figure 4: North America Molecular Point of Care Diagnostics Market, by Instruments, 2019-2028 (In $ Million)
Figure 5: North America Molecular Point of Care Diagnostics Market, by Software, 2019-2028 (In $ Million)
Figure 6: North America Molecular Point of Care Diagnostics Market, by Infectious Disease, 2019-2028 (In $ Million)
Figure 7: North America Molecular Point of Care Diagnostics Market, by Respiratory, 2019-2028 (In $ Million)
Figure 8: North America Molecular Point of Care Diagnostics Market, by Hospital-Acquired Infections, 2019-2028 (In $ Million)
Figure 9: North America Molecular Point of Care Diagnostics Market, by Sexually-Transmitted Infections, 2019-2028 (In $ Million)
Figure 10: North America Molecular Point of Care Diagnostics Market, by Gastrointestinal Infections, 2019-2028 (In $ Million)
Figure 11: North America Molecular Point of Care Diagnostics Market, by Oncology, 2019-2028 (In $ Million)
Figure 12: North America Molecular Point of Care Diagnostics Market, by Prenatal, 2019-2028 (In $ Million)
Figure 13: North America Molecular Point of Care Diagnostics Market, by Others, 2019-2028 (In $ Million)
Figure 14: North America Molecular Point of Care Diagnostics Market, by Polymerase Chain Reaction, 2019-2028 (In $ Million)
Figure 15: North America Molecular Point of Care Diagnostics Market, by Real-Time Pcr (Q-Pcr), 2019-2028 (In $ Million)
Figure 16: North America Molecular Point of Care Diagnostics Market, by Digital Pcr (D-Pcr), 2019-2028 (In $ Million)
Figure 17: North America Molecular Point of Care Diagnostics Market, by Isothermal Nucleic Acid Amplification Technology, 2019-2028 (In $ Million)
Figure 18: North America Molecular Point of Care Diagnostics Market, by Other, 2019-2028 (In $ Million)
Figure 19: North America Molecular Point of Care Diagnostics Market, by Hospital, 2019-2028 (In $ Million)
Figure 20: North America Molecular Point of Care Diagnostics Market, by Clinics, 2019-2028 (In $ Million)
Figure 21: North America Molecular Point of Care Diagnostics Market, by Diagnostic Centers, 2019-2028 (In $ Million)
Figure 22: North America Molecular Point of Care Diagnostics Market, by Others, 2019-2028 (In $ Million)
Figure 23: North America Molecular Point of Care Diagnostics Market, Regional Outlook, 2018 & 2028 (In %)
Figure 24: United States Molecular Point of Care Diagnostics Market, 2019-2028 (In $ Million)
Figure 25: Canada Molecular Point of Care Diagnostics Market, 2019-2028 (In $ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott
  • Abacus Diagnostica
  • Biomerieux SA
  • Biocartis
  • Danaher
  • Diasorin SPA
  • Bio-Rad Laboratories Inc
  • F Hoffmann-La Roche Ltd
  • Luminex Corporation
  • Hologic Inc
  • Mesa Biotech
  • Spartan Biosciences Inc
  • Quantumdx Group Ltd
  • Quidel Corporation
  • Qiagen

Methodology

Loading
LOADING...